Exicure (XCUR) Other Working Capital Changes (2016 - 2023)
Exicure's (XCUR) quarterly Other Working Capital Changes came in at $105000.0 in Q2 2023, down 95.93% YoY from $2.6 million in Q2 2022, and up 200.0% on a QoQ basis from -$105000.0 in Q1 2023.
Exicure (XCUR) Other Working Capital Changes (2016 - 2023) Analysis & Trends
Exicure (XCUR) has 8 years of Other Working Capital Changes data on file, last reported at $105000.0 in Q2 2023.
- Quarterly Other Working Capital Changes fell 95.93% year-over-year to $105000.0 in Q2 2023, while the trailing twelve-month figure through Sep 2023 was -$21.8 million (down 208.81% YoY) and the FY2022 annual result came in at -$28.8 million, down 411900.0% from the prior year.
- Other Working Capital Changes climbed to $105000.0 in Q2 2023, from -$105000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $127000.0 in Q3 2025 to a low of -$1.7 million in Q1 2022.
- A 5-year average of -$282470.6 and a median of -$157000.0 in 2023 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2019 — Other Working Capital Changes soared 34200.0% — and 2022, when it sank 2177500.0%.
- Tracing XCUR's Other Working Capital Changes over 5 years: stood at $22000.0 in 2019, then plunged by 95.45% to $1000.0 in 2020, then changed by 0.0% to $1000.0 in 2021, then slumped by 2177500.0% to -$21.8 million in 2022, then surged by 100.48% to $105000.0 in 2023.
- The last three Other Working Capital Changes figures came in at $105000.0 (Q2 2023), -$105000.0 (Q1 2023), and -$21.8 million (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Exicure | 7.27 Mn | 7.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 105,000.00 |
| Jun 30, 2023 | 105,000.00 |
| Jun 30, 2023 | 105,000.00 |
| Mar 31, 2023 | -105,000.00 |
| Mar 31, 2023 | -105,000.00 |
| Mar 31, 2023 | -105,000.00 |
| Dec 31, 2022 | -21.77 Mn |
| Dec 31, 2022 | -21.77 Mn |
| Dec 31, 2022 | -21.77 Mn |
| Sep 30, 2022 | -7.07 Mn |
| Sep 30, 2022 | -7.07 Mn |
| Sep 30, 2022 | -7.07 Mn |
| Jun 30, 2022 | 2.58 Mn |
| Jun 30, 2022 | 2.58 Mn |
| Jun 30, 2022 | 2.58 Mn |
| Mar 31, 2022 | -2.57 Mn |
| Mar 31, 2022 | -2.57 Mn |
| Mar 31, 2022 | -2.57 Mn |
| Dec 31, 2021 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |